© Reuters. FILE PHOTO: Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna (NASDAQ:) Inc’s COVID-19 vaccine for children and teens aged 6 to 17 years of age.
Be the first to comment